PDF(Pubmed)
Abstract：
Polycystic ovary syndrome (PCOS) affects about 12% of women of reproductive age. In 2018, the first evidence-based guideline on assessment and management of PCOS was published, and an updated extended guideline was released in August 2023. These guidelines followed best practice and are endorsed by 39 organizations worldwide, making them the most robust source of evidence to guide clinical practice. In the 2023 guideline, diagnostic criteria have been further refined as polycystic ovary morphology can now be assessed with gynecological ultrasound or elevated anti-Müllerian hormone levels. A healthy lifestyle should be at the focus of care for all women with PCOS; however, with no specific diet or physical exercise recommended. The latest evidence on medical treatments and fertility management are reviewed, including special considerations regarding long-term follow-up of metabolic and psychiatric comorbidities and pregnancy in women with PCOS. Here we summarize the recommendations from a Nordic perspective.
摘要：
多囊卵巢综合征（PCOS）影响约12％的育龄妇女。2018年，第一个基于证据的PCOS评估和管理指南发布。更新的扩展指南于2023年8月发布.这些准则遵循了最佳做法，并得到了全球39个组织的认可，使它们成为指导临床实践的最有力的证据来源。在2023年的指导方针中，由于多囊卵巢形态现在可以通过妇科超声或升高的抗苗勒管激素水平进行评估,因此诊断标准得到了进一步完善.健康的生活方式应该是所有PCOS女性护理的重点;然而，没有特定的饮食或体育锻炼建议。对药物治疗和生育管理的最新证据进行了审查，包括对PCOS患者代谢和精神合并症的长期随访以及妊娠的特殊考虑。在这里，我们从北欧的角度总结了建议。
